Related Experiment Videos
Skeletal muscle ventricle aortic counterpulsation: function during chronic heart failure
Bhavik G Patel1, Sachin H Shah, Lou I Astra
1Department of Surgery, Wayne State University, Detroit, Michigan, USA.
The Annals of Thoracic Surgery
|February 16, 2002
Summary
Skeletal muscle ventricles (SMVs) effectively augment diastolic pressure and improve cardiac function in a canine model of chronic heart failure. This study demonstrates the potential of SMV aortic counterpulsation for advanced cardiac support.
Area of Science:
- Biomedical Engineering
- Cardiovascular Surgery
- Regenerative Medicine
Background:
- Skeletal muscle ventricles (SMVs) are engineered pumping chambers utilizing latissimus dorsi muscle.
- Previous studies confirmed SMV aortic counterpulsator stability and efficacy in normal canines.
- This research investigates SMV aortic counterpulsator performance in a chronic heart failure model.
Purpose of the Study:
- To evaluate the effectiveness of the SMV aortic counterpulsator in a canine model of chronic heart failure.
- To assess the impact of SMV counterpulsation on hemodynamic parameters in a failing heart.
Main Methods:
- Six dogs underwent creation of pericardium-lined SMVs from latissimus dorsi muscle, with electrical conditioning for fatigue resistance.
- SMVs were connected to the descending thoracic aorta, and rapid ventricular pacing induced chronic heart failure over 7 weeks.
- SMV stimulation during cardiac diastole was performed at a 1:2 to 1:3 ratio.
Main Results:
- SMV contraction increased diastolic pressure time-index by 12.1% at baseline and 33.6% after 7 weeks of heart failure.
- Counterpulsation led to significant afterload reduction, increasing peak left ventricular ejection velocity by 22.7% and stroke volume by 6.2%.
- Coronary blood flow augmentation averaged 47.6% in measurements taken at 7 weeks.
Conclusions:
- The SMV aortic counterpulsator demonstrates significant improvement in cardiac assistance for a failing heart.
- This technology shows promise as a viable option for advanced cardiac support in heart failure patients.